Tutorial
Robinhood Chain
…
Wallet
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Alerts on Telegram
Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
Enveric Biosciences, Inc. (ENVB) · INSIDER
Data sources
SEC Form 4
48m ago
House PTR
48m ago
SEC 13F
48m ago
Robinhood Chain
48m ago
Public company
Enveric Biosciences, Inc.
ENVB
CIK 0000890821
EDGAR filings
Open in network
○
Watch ENVB
Price
$1.42
1 year
-80.3%
Disclosed transactions
1
Buys / sells
0 / 0
Max Insider Score
21
Connections with evidence
3
Customize layout
ENVB · disclosed activity on price
Disclosed transactions
Score
Actor
Security
Side
Value
Executed
Disclosed
Lag
Source
Evidence
21
DS
DeWitt Sheila
Director
ENVB
Enveric Biosciences, Inc.
Grant or award
A
—
18.5K sh
Jun 1, 2026
Jun 3, 2026
Verified connections
In industry
evidence
Pharmaceuticals, devices & health services
SEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
← Holds over 5% of
evidence
Sio Capital Management, LLC
7.37% of class · Schedule 13G · Nov 2, 2026
← Insider of
evidence
DeWitt Sheila
Director · Jun 3, 2026
traded Jun 1, 2026
+2d
SEC Form 4
Evidence
Evidence
Close
Planned sales and 5% stakes
Form 144, 13D and 13G
Sio Capital Management, LLC
Passive holder · crossed on Sep 30, 2026 · 330.0K shares
7.37% of class
13G · filed Nov 3, 2026
Disclosed trades
TradingView